Choreño-Parra, J. A., Jiménez-Álvarez, L. A., Ramírez-Martínez, G., Sandoval-Vega, M., Salinas-Lara, C., Sánchez-Garibay, C., . . . Zúñiga, J. (2021). Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome. Front Immunol.
Stile di citazione ChicagoChoreño-Parra, Jose Alberto, et al. "Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome." Front Immunol 2021.
Citazione MLAChoreño-Parra, Jose Alberto, et al. "Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome." Front Immunol 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.